
J&J’s once-daily pill eases psoriatic arthritis symptoms in late-stage trial
Johnson & Johnson (JNJ) said its once-daily pill eased symptoms in more patients with psoriatic arthritis than a placebo in a late-stage trial, potentially supporting expanded use of the drug. The company said 58 per cent of patients…
